US 11,926,653 B2
Methods and materials for NT-3 gene therapy
Zarife Sahenk, Columbus, OH (US)
Assigned to RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL, Columbus, OH (US)
Appl. No. 16/757,176
Filed by RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL, Columbus, OH (US)
PCT Filed Oct. 19, 2018, PCT No. PCT/US2018/056765
§ 371(c)(1), (2) Date Apr. 17, 2020,
PCT Pub. No. WO2019/079755, PCT Pub. Date Apr. 25, 2019.
Claims priority of provisional application 62/741,335, filed on Oct. 4, 2018.
Claims priority of provisional application 62/676,687, filed on May 25, 2018.
Claims priority of provisional application 62/574,828, filed on Oct. 20, 2017.
Prior Publication US 2020/0339960 A1, Oct. 29, 2020
Int. Cl. C07K 14/475 (2006.01); A61K 48/00 (2006.01); A61P 25/00 (2006.01); C12N 15/86 (2006.01)
CPC C07K 14/475 (2013.01) [A61K 48/0058 (2013.01); A61K 48/0075 (2013.01); A61P 25/00 (2018.01); C12N 15/86 (2013.01); C12N 2750/14143 (2013.01); C12N 2830/15 (2013.01); C12N 2830/50 (2013.01)] 26 Claims
 
1. A nucleic acid comprising a nucleotide sequence that is at least 90% identical to SEQ ID NO: 11.